IP Group news .

IP Group plc

Portfolio company Oxford Nanopore Technologies announces LamPORE test, for the detection of SARS-CoV-2, gains CE-IVD mark with initial roll out in Europe and the UAE

IP Group plc

Portfolio company Enterprise Therapeutics’ TMEM16A potentiator program for treatment of cystic fibrosis & other respiratory diseases acquired by Roche

IP Group plc

Portfolio company MOBILion Systems completes $35m funding round

IP Group plc

Half-yearly results

IP Group plc

Launches £12m Investment Partnership in Quantum Technologies with InnovateUK

IP Group plc

Portfolio company Oxford Nanopore Technologies partners with UK Government to roll out LamPORE, a new generation of COVID-19 test

IP Group plc

Sells 9.16m shares in Ceres Power; cash realisations for the year now exceed £168m

IP Group plc

Appoints Gordon Clark, Emeritus Professor, Oxford University as Chair of ESG Ethics Committee

IP Group plc

AGM Statement

IP Group plc

Portfolio company Inivata announces strategic collaboration and $25m investment from NeoGenomics